Prescription Drug Monitoring: States Can Readily Identify Illegal Sales and Use of Controlled Substances

Pursuant to a congressional request, GAO provided information on state prescription drug monitoring programs, focusing on: (1) program benefits to investigations and their effectiveness in detecting and reducing drug diversion; (2) whether savings have resulted from reductions in Medicaid prescription drug claims; and (3) adverse effects on medical practice and patient care.